The integration of computational approaches into clinical cancer practice has the potential to revolutionize diagnosis, treatment, and patient outcomes. Technological advances in machine learning, bioinformatics, and artificial intelligence have led to breakthroughs in cancer detection, predictive modeling, and personalized therapy. Computational tools such as deep learning models, next-generation sequencing, and advanced imaging techniques promise greater diagnostic accuracy and more tailored treatment strategies. Despite their transformative potential, the practical application of these approaches in clinical settings remains a significant challenge. Barriers include issues related to data quality, the complexity of integrating multi-omics data, and the reluctance of healthcare professionals to adopt new technologies due to concerns about accuracy, reliability, and interpretability. Additionally, the lack of standardized protocols, the need for extensive training, and ethical concerns around data privacy and algorithmic bias further hinder the widespread implementation of computational tools. This chapter explores these challenges in detail, highlighting both technical and nontechnical obstacles, and proposes strategies for overcoming them. Addressing these barriers is crucial to bridging the gap between theoretical advancements and real-world clinical practice, ultimately ensuring that computational approaches can enhance cancer care, improve patient outcomes, and drive the next generation of personalized medicine.